These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22036020)

  • 41. Assessing movement quality in persons with severe mental illness - Reliability and validity of the Body Awareness Scale Movement Quality and Experience.
    Hedlund L; Gyllensten AL; Waldegren T; Hansson L
    Physiother Theory Pract; 2016 May; 32(4):296-306. PubMed ID: 27050236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia.
    Huang M; Huang Y; Yu L; Hu J; Chen J; Jin P; Xu W; Wei N; Hu S; Qi H; Xu Y
    BMC Psychiatry; 2016 Oct; 16(1):344. PubMed ID: 27716115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of neurocognitive deficits and unawareness of illness in schizophrenia.
    Lysaker PH; Lancaster RS; Davis LW; Clements CA
    J Nerv Ment Dis; 2003 Jan; 191(1):38-44. PubMed ID: 12544598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment.
    Baumstarck K; Boyer L; Boucekine M; Aghababian V; Parola N; Lançon C; Auquier P
    Schizophr Res; 2013 Jun; 147(1):58-67. PubMed ID: 23566495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?
    Balzan RP; Neaves A; Denson LA; Liu D; Galletly C
    Cogn Neuropsychiatry; 2014; 19(6):471-84. PubMed ID: 24749790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function.
    Kleinman L; Lieberman J; Dube S; Mohs R; Zhao Y; Kinon B; Carpenter W; Harvey PD; Green MF; Keefe RS; Frank L; Bowman L; Revicki DA
    Schizophr Res; 2009 Feb; 107(2-3):275-85. PubMed ID: 19013769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between insight and theory of mind in schizophrenia.
    Konstantakopoulos G; Ploumpidis D; Oulis P; Patrikelis P; Nikitopoulou S; Papadimitriou GN; David AS
    Schizophr Res; 2014 Jan; 152(1):217-22. PubMed ID: 24321712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.
    Tumkaya S; Karadag F; Oguzhanoglu NK; Tekkanat C; Varma G; Ozdel O; Ateşçi F
    Psychiatry Res; 2009 Jan; 165(1-2):38-46. PubMed ID: 18995914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICS.
    Lecardeur L; Briand C; Prouteau A; Lalonde P; Nicole L; Lesage A; Stip E
    Schizophr Res; 2009 Feb; 107(2-3):303-6. PubMed ID: 18835134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability.
    Voruganti L; Heslegrave R; Awad AG; Seeman MV
    Psychol Med; 1998 Jan; 28(1):165-72. PubMed ID: 9483693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder.
    Chianetta JM; Lefebvre M; LeBlanc R; Grignon S
    Schizophr Res; 2008 Oct; 105(1-3):86-94. PubMed ID: 18790606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of the Persian version of the brief assessment of cognition in schizophrenia in patients with schizophrenia and healthy controls.
    Mazhari S; Parvaresh N; Eslami Shahrbabaki M; Sadeghi MM; Nakhaee N; Keefe RS
    Psychiatry Clin Neurosci; 2014 Feb; 68(2):160-6. PubMed ID: 24552637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
    Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insight into illness, neurocognition and quality of life in schizophrenia.
    Boyer L; Aghababian V; Richieri R; Loundou A; Padovani R; Simeoni MC; Auquier P; Lançon C
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):271-6. PubMed ID: 22019603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insight change in psychosis: relationship with neurocognition, social cognition, clinical symptoms and phase of illness.
    Quee PJ; van der Meer L; Krabbendam L; de Haan L; Cahn W; Wiersma D; van Beveren N; Pijnenborg GH; Mulder CL; Bruggeman R; Aleman A
    Acta Psychiatr Scand; 2014 Feb; 129(2):126-33. PubMed ID: 23600752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.
    Keefe RS; Goldberg TE; Harvey PD; Gold JM; Poe MP; Coughenour L
    Schizophr Res; 2004 Jun; 68(2-3):283-97. PubMed ID: 15099610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of treatment utilisation at cognitive remediation groups for schizophrenia: the roles of neuropsychological, psychological and clinical variables.
    Gooding AL; Saperstein A; Rivera Mindt M; Medalia A
    Neuropsychol Rehabil; 2012; 22(4):516-31. PubMed ID: 22390152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.